Purdue Pharma Reaches New $7.4 Billion Opioid Crisis Settlement
Purdue Pharma and its owners, the Sackler family, have negotiated a revised $7.4 billion settlement to resolve litigation over OxyContin's role in the opioid epidemic. This agreement follows the Supreme Court's rejection of a previous attempt.
Purdue Pharma and the Sackler family that own the company have agreed to a $7.4 billion settlement in principle with 15 states over its role in the opioid crisis.
Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback